Cargando…
Reconstructing disease dynamics for mechanistic insights and clinical benefit
Diseases change over time, both phenotypically and in their underlying molecular processes. Though understanding disease progression dynamics is critical for diagnostics and treatment, capturing these dynamics is difficult due to their complexity and the high heterogeneity in disease development bet...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611752/ https://www.ncbi.nlm.nih.gov/pubmed/37891175 http://dx.doi.org/10.1038/s41467-023-42354-8 |
_version_ | 1785128551646756864 |
---|---|
author | Frishberg, Amit Milman, Neta Alpert, Ayelet Spitzer, Hannah Asani, Ben Schiefelbein, Johannes B. Bakin, Evgeny Regev-Berman, Karen Priglinger, Siegfried G. Schultze, Joachim L. Theis, Fabian J. Shen-Orr, Shai S. |
author_facet | Frishberg, Amit Milman, Neta Alpert, Ayelet Spitzer, Hannah Asani, Ben Schiefelbein, Johannes B. Bakin, Evgeny Regev-Berman, Karen Priglinger, Siegfried G. Schultze, Joachim L. Theis, Fabian J. Shen-Orr, Shai S. |
author_sort | Frishberg, Amit |
collection | PubMed |
description | Diseases change over time, both phenotypically and in their underlying molecular processes. Though understanding disease progression dynamics is critical for diagnostics and treatment, capturing these dynamics is difficult due to their complexity and the high heterogeneity in disease development between individuals. We present TimeAx, an algorithm which builds a comparative framework for capturing disease dynamics using high-dimensional, short time-series data. We demonstrate the utility of TimeAx by studying disease progression dynamics for multiple diseases and data types. Notably, for urothelial bladder cancer tumorigenesis, we identify a stromal pro-invasion point on the disease progression axis, characterized by massive immune cell infiltration to the tumor microenvironment and increased mortality. Moreover, the continuous TimeAx model differentiates between early and late tumors within the same tumor subtype, uncovering molecular transitions and potential targetable pathways. Overall, we present a powerful approach for studying disease progression dynamics—providing improved molecular interpretability and clinical benefits for patient stratification and outcome prediction. |
format | Online Article Text |
id | pubmed-10611752 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-106117522023-10-29 Reconstructing disease dynamics for mechanistic insights and clinical benefit Frishberg, Amit Milman, Neta Alpert, Ayelet Spitzer, Hannah Asani, Ben Schiefelbein, Johannes B. Bakin, Evgeny Regev-Berman, Karen Priglinger, Siegfried G. Schultze, Joachim L. Theis, Fabian J. Shen-Orr, Shai S. Nat Commun Article Diseases change over time, both phenotypically and in their underlying molecular processes. Though understanding disease progression dynamics is critical for diagnostics and treatment, capturing these dynamics is difficult due to their complexity and the high heterogeneity in disease development between individuals. We present TimeAx, an algorithm which builds a comparative framework for capturing disease dynamics using high-dimensional, short time-series data. We demonstrate the utility of TimeAx by studying disease progression dynamics for multiple diseases and data types. Notably, for urothelial bladder cancer tumorigenesis, we identify a stromal pro-invasion point on the disease progression axis, characterized by massive immune cell infiltration to the tumor microenvironment and increased mortality. Moreover, the continuous TimeAx model differentiates between early and late tumors within the same tumor subtype, uncovering molecular transitions and potential targetable pathways. Overall, we present a powerful approach for studying disease progression dynamics—providing improved molecular interpretability and clinical benefits for patient stratification and outcome prediction. Nature Publishing Group UK 2023-10-27 /pmc/articles/PMC10611752/ /pubmed/37891175 http://dx.doi.org/10.1038/s41467-023-42354-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Frishberg, Amit Milman, Neta Alpert, Ayelet Spitzer, Hannah Asani, Ben Schiefelbein, Johannes B. Bakin, Evgeny Regev-Berman, Karen Priglinger, Siegfried G. Schultze, Joachim L. Theis, Fabian J. Shen-Orr, Shai S. Reconstructing disease dynamics for mechanistic insights and clinical benefit |
title | Reconstructing disease dynamics for mechanistic insights and clinical benefit |
title_full | Reconstructing disease dynamics for mechanistic insights and clinical benefit |
title_fullStr | Reconstructing disease dynamics for mechanistic insights and clinical benefit |
title_full_unstemmed | Reconstructing disease dynamics for mechanistic insights and clinical benefit |
title_short | Reconstructing disease dynamics for mechanistic insights and clinical benefit |
title_sort | reconstructing disease dynamics for mechanistic insights and clinical benefit |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611752/ https://www.ncbi.nlm.nih.gov/pubmed/37891175 http://dx.doi.org/10.1038/s41467-023-42354-8 |
work_keys_str_mv | AT frishbergamit reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit AT milmanneta reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit AT alpertayelet reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit AT spitzerhannah reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit AT asaniben reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit AT schiefelbeinjohannesb reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit AT bakinevgeny reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit AT regevbermankaren reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit AT priglingersiegfriedg reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit AT schultzejoachiml reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit AT theisfabianj reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit AT shenorrshais reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit |